← Evidence map

ArticleCancer2025

Correction to "Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-06)".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Correction to "Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-06)". | OpenQuestion